Mycophenolic acid analogues as anti-tumor chemosensitizing agents
Abstract
In some embodiments, the present invention provides methods of treating a tumor in a subject. In some embodiments, the methods may include a step of administering to the subject a therapeutic composition that comprises: (a) mycophenolic acid, an analog thereof, or a derivative thereof; and (b) at least one anti-neoplastic agent. In some embodiments, the antineoplastic agent may include at least one of 5-fluouracil (5-FU), paclitaxel, oxaliplatin, doxorubicin, etoposide, irinotecan, bleomycin, imiquimod, 13-cis-retinoic acid, and combinations thereof. In some embodiments, the relative concentrations of the mycophenolic acid, the analog thereof, or the derivative thereof, and the at least one anti-neoplastic agent correspond to their respective IC50 values. In some embodiments, the methods of the present invention may be used to treat tumors associated with at least one of an oral cancer, a skin cancer, a breast cancer, a prostate cancer, precancerous lesions thereof, hyperplastic lesions thereof, and benign tumors thereof.
Subject
A61K 31/365A61K 31/203
A61K 31/282
A61K 31/337
A61K 31/4745
A61K 31/513
A61K 31/555
A61K 31/704
A61K 31/7048
A61K 38/14
A61K 45/06
Collections
Citation
Tsai, Robert Y.; Lin, Tao (2016). Mycophenolic acid analogues as anti-tumor chemosensitizing agents. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from https : / /hdl .handle .net /1969 .1 /177177.